Serum lipoprotein(a) predicts 1-year major cardiovascular events in patients after percutaneous coronary intervention.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Lipoprotein(a) [Lp(a)], which is predictive of coronary heart disease (CHD), plays an important role in the pathogenesis of atherosclerosis. This study aimed to evaluate the association of Lp(a) with major adverse cardiovascular events (MACEs) and readmission in individuals who had undergone a percutaneous coronary intervention (PCI).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am J Transl Res

Title: American journal of translational research

Publisher:

ISSN: 1943-8141

ISSN (Print): 1943-8141

Publication date (Electronic): 2023

Volume: 15

Issue: 1

Affiliations

[1 ] Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University Jinan 250012, Shandong, China.

[2 ] Department of Clinical Nutrition, Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan 250021, Shandong, China.

[3 ] Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan 250021, Shandong, China.

[4 ] Department of Cardiology, Fuwai Hospital Beijing 100037, China.

[5 ] Department of Cardiology, Shandong Provincial Hospital, Shandong University Jinan 250021, Shandong, China.

Article

PMC ID: 9908492

PubMed ID: 36777853

SO-VID: b492a2c9-86d1-4aef-8911-ca97349378ab

History

Keywords: percutaneous coronary intervention,readmission,Lp(a),major cardiovascular event

Data availability:

Keywords: percutaneous coronary intervention, readmission, Lp(a), major cardiovascular event

Comments

Comment on this article

Cited by 4

See all cited by